| The History of the MSRC
The mission of
the Mass Spectrometry Research Center (MSRC) is to bring state-of-the-art mass
spectrometry expertise, methodology, and instrumentation to the research and
clinical infrastructure of the
Vanderbilt
University
Medical
Center
. Dr.
Richard Caprioli joined
Vanderbilt
University
in early 1998
to reorganize and further enhance an existing MS facility; the MSRC was
established in May of 1998. Dr. David
Hachey was recruited later in 1998 to direct the Mass Spectrometry (small
molecule) Core laboratory. Because of the rapid growth in demand for proteomics
services the MSRC formally established a separate Proteomics Laboratory that is
currently lead by Dr. David Hachey.
In September 2003 the MSRC moved into
new facilities in Medical Research Building III that provided a more than
2-fold increase in space. The
Bioanalytical Core currently occupies about 3,800 square feet of laboratory
space on the 9th floor of the MRB III that is contiguous with that
occupied by the Proteomics Core (3,600 sq ft). Support for the facility comes from service cores affiliated with seven
NIH-funded Program Projects and
Research
Centers
, service fees
charged to unaffiliated investigators and direct institutional support from
Vanderbilt
University
. The Research and Development laboratories of
Dr. Caprioli comprise 5,500 sq ft. of space on the 9th floor of the
MRB III and the Tissue Imaging/Serum Biofluids core is enveloped within these
three existing service centers.
The
MSRC has protocols and instrumentation to form a critical mass in proteomics
with established support from the
Vanderbilt
Ingram
Cancer
Center
, the
Molecular
Toxicology
Center
,
the Breast SPORE Grant and the
Vanderbilt
Vision
Research
Center
. The Mass Spectrometry (small molecule) Core
provides outstanding collaboration, consultation, and equipment to research
investigators throughout the University. The Mass Spectrometry Research and Development Lab continues to provide
the
Medical
Center
with cutting-edge instrumentation
and methods, including close collaborations with clinicians through
translational research. The most recent undertaking of the MSRC is the
establishment of the Tissue Profiling/Imaging Laboratory to provide expertise
in molecular analysis of tissues and biological fluids. The mission of this Core is to provide
expertise for the analysis of complex proteomes of tissue samples to provide
information that can facilitate the detection of disease states, responses to
therapy and drug toxicity. Proteome profiling identifies mass spectral patterns
derived from multiple proteins in a tissue sample. Proteome imaging can
be done by analyzing mass spectral data acquired across a grid within a tissue
section. Proteomic patterns can be analyzed with bioinformatics and
biostatistical methods to identify sets of diagnostic spectral markers.
Identification of the proteins and protein fragments that account for biomarker
signals is done in collaboration with the Proteomics Core Laboratory.
The amount and complexity of the data generated by the MSRC requires both an active development and support staff to be available to address the needs of the mass spectrometry-based research enterprise at Vanderbilt. The MSRC's bioinformatics core is actively engaged in both systems and algorithm development to facilitate the analysis and correlation of mass spectral data and clinical information. The core's support component provides systems support and storage management to members of the facility.
The
MSRC conducts collaborative research programs with investigators in nearly
every Center and department in the
Medical
Center
as well as many
trans-Institutional initiatives in the Departments of Chemistry, Physics &
Astronomy, Biological Sciences and Electrical Engineering & Computer
Science. Other areas include:
Pharmacology, Medicine, Cell & Developmental Biology, Anesthesiology,
Psychiatry, Molecular Physiology & Biophysics, Infectious Diseases, Pediatrics,
Orthopedics, Hematology/Oncology, Microbiology and Immunology, Surgical
Urology, Otolaryngology, Allergy/Pulmonary, Surgical Sciences, Biochemistry,
Radiation Oncology, Clinical Pharmacology, Gastroenterology, Pathology,
Nephrology, and Cardiovascular Medicine, Structural Biology, Institute for
Molecular Neuroscience, Vanderbilt Ingram Cancer Center (VICC), Digestive
Disease Research Center, General Clinical Research Center, Clinical Nutrition
Research Unit, and the Molecular Toxicology Research Center. Over 200 investigators currently use the
facilities, most as an on-going part of their research programs. In particular, the Proteomics Core facility
plays major roles not only in the Cancer Center (VICC), but also in the three
funded SPORES (GI, Lung and Breast). It
is also a major part of the facilities available to the newly formed Chemical
Biology Institute. We also have
collaborative arrangements with faculty members at the
Meharry
Medical
College
.
In addition, contracts to
Vanderbilt
University
for research in drug
metabolism include some of the largest and most prestigious pharmaceutical
companies. The basic goal of most of
these projects is the measurement of the site of arrival of a drug, a measure
of its relative metabolism, and its effect on the protein concentrations at the
site of arrival as compared to other areas.
The current configuration of the MSRC,
with four core laboratories and a research and development laboratory,
currently houses 40 mass spectrometers and has served over 400 users over the
past 12 months, making it one of the premier Mass Spectrometry centers in the
United States.
|